Back to Search Start Over

Single-cell transcriptome analysis of the mouse lungs during the injury and recovery periods after lipopolysaccharide administration.

Authors :
Wang HP
He J
He JR
Li DD
Huang H
Chen B
Source :
Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2024 Dec; Vol. 73 (12), pp. 2087-2107. Date of Electronic Publication: 2024 Oct 08.
Publication Year :
2024

Abstract

Objective: This study sought to investigate the cellular and molecular alterations during the injury and recovery periods of ALI and develop effective treatments for ALI.<br />Methods: Pulmonary histology at 1, 3, 6, and 9 days after lipopolysaccharide administration mice were assessed. An unbiased single-cell RNA sequencing was performed in alveoli tissues from injury (day 3) and recovery (day 6) mice after lipopolysaccharide administration. The roles of Fpr2 and Dpp4 in ALI were assessed.<br />Results: The most severe lung injury occurred on day 3, followed by recovery entirely on day 9 after lipopolysaccharide administration. The numbers of Il1a <superscript>+</superscript> neutrophils, monocytes/macrophages, and Cd4 <superscript>+</superscript> and Cd8 <superscript>+</superscript> T cells significantly increased at day 3 after LPS administration; subsequently, the number of Il1a <superscript>+</superscript> neutrophils greatly decreased, the numbers of monocytes/macrophages and Cd4 <superscript>+</superscript> and Cd8 <superscript>+</superscript> T cells continuously increased, and the number of resident alveolar macrophages significantly increased at day 6. The interactions between monocytes/macrophages and pneumocytes during the injury period were enhanced by the Cxcl10/Dpp4 pair, and inhibiting Dpp4 improved ALI significantly, while inhibiting Fpr2 did not.<br />Conclusions: Our results offer valuable insights into the cellular and molecular mechanisms underlying its progression and identify Dpp4 as an effective therapeutic target for ALI.<br />Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.<br /> (© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)

Details

Language :
English
ISSN :
1420-908X
Volume :
73
Issue :
12
Database :
MEDLINE
Journal :
Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Publication Type :
Academic Journal
Accession number :
39377802
Full Text :
https://doi.org/10.1007/s00011-024-01951-z